Reteplase Superior to Alteplase in Chinese Stroke Trial

The double-bolus thrombolytic gave a higher rate of excellent functional outcomes in the RAISE trial.
Medscape Medical News

source https://www.medscape.com/viewarticle/reteplase-superior-alteplase-chinese-stroke-trial-2024a1000c55?src=rss

Comments

Popular posts from this blog

New AAFP practice guideline sets blood pressure targets for adults with hypertension

RA and RA-ILD Linked to Higher Lung Cancer Risk

A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?